20406 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom; Quinolines; Isoquinolines Cinchonan derivatives, e.g. quinine
TASIPIMIDINE AND CYP2D6 INHIBITOR COMBINATION TREATMENT
#2RIBONUCLEASES FOR TREATING VIRAL INFECTIONS
#3COMPOUNDS AND COMBINATIONS THEREOF FOR TREATING NEUROLOGICAL AND PSYCHIATRIC CONDITIONS
#4FERROCHELATASE INHIBITORS AND METHODS OF USE
#5COMBINATION OF 5-AMINO-2,3-DIHYDRO-1,4-PHTALAZINEDIONE AND A 6'-METHOXYCINCHONAN-9-OL FOR USE IN THE TREATMENT OF CORONAVIRAL INFECTIONS
#6METHODS AND COMPOSITIONS FOR USE IN IMPROVING ADAPTIVE IMMUNITY IN THE ELDERLY POPULATION
#7USE OF COMPOUNDS IN INHIBITING OR KILLING MITES AND TREATING XEROPHTHALMIA
#8METHODS FOR THE COMBINED ADMINISTRATION OF DEUTETRABENAZINE AND A CYP2D6 INHIBITOR
#9FOOD SUPPLEMENT TO PROMOTE BODY WEIGHT LOSS
#10Morphinan compounds
#11MORPHINAN COMPOUNDS
#12PHARMACEUTICAL COMPOSITIONS COMPRISING A DEXTROMETHORPHAN COMPOUND AND QUINIDINE FOR THE TREATMENT OF AGITATION IN DEMENTIA
#13COMPOUNDS FOR TREATMENT OF HEMOLYSIS-AND INFLAMMASOME-ASSOCIATED DISEASES
#14Pain Medicine Combination and Uses Thereof
#15COMPOSITIONS AND METHODS FOR TREATING CORONAVIRUS
#166'-METHOXYCINCHONAN-9-OLS FOR THE TREATMENT OF CORONAVIRAL INFECTIONS
#17QUININE AND ITS USE TO GENERATE INNATE IMMUNE RESPONSE
#18SYK KINASE INHIBITORS AS TREATMENT FOR MALARIA
#19PHARMACEUTICAL COMPOSITIONS COMPRISING DEXTROMETHORPHAN AND QUINIDINE FOR THE TREATMENT OF DEPRESSON, ANXIETY, AND NEURODEGENERATIVE DISORDERS
#20PHARMACEUTICAL COMPOSITIONS COMPRISING DEXTROMETHORPHAN AND QUINIDINE FOR THE TREATMENT OF AGITATION IN DEMENTIA
#21METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING CENTRAL NERVOUS SYSTEM DISORDERS AND OTHER CONDITIONS CAUSED BY GUT MICROBIAL DYSBIOSIS
#22METHODS OF TREATING NEGATIVE SYMPTOMS OF SCHIZOPHRENIA USING DEUTERATED DEXTROMETHORPHAN AND QUINIDINE
#23COMPOSITIONS AND METHODS FOR DIETARY ENHANCEMENT OF IMMUNE SYSTEM FUNCTION
#24Morphinan compounds
#25Quinoline derivatives with other anti-viral agents
#26QUININE AND ITS USE TO GENERATE INNATE IMMUNE RESPONSE
#27FIBRILLAR-PROTEIN BASED COMPOSITIONS AND USES THEREOF
#28Ferrochelatase inhibitors and methods of use
#29TREATMENT OF NEURODEGENERATIVE DISEASES
#30PHARMACEUTICAL COMPOSITIONS COMPRISING DEXTROMETHORPHAN AND QUINIDINE FOR THE TREATMENT OF DEPRESSION, ANXIETY, AND NEURODEGENERATIVE DISORDERS
#31PHARMACEUTICAL COMPOSITIONS COMPRISING DEXTROMETHORPHAN AND QUINIDINE FOR THE TREATMENT OF AGITATION IN DEMENTIA
#32SYK KINASE INHIBITORS AS TREATMENT FOR MALARIA
#33Pain Medicine Combination and Uses Thereof
#34PHARMACEUTICAL COMPOSITIONS COMPRISING A DEXTROMETHORPHAN COMPOUND AND QUINIDINE FOR THE TREATMENT OF AGITATION IN DEMENTIA
#35PHARMACEUTICAL COMPOSITIONS COMPRISING DEXTROMETHORPHAN AND QUINIDINE FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
#36Hydrogel toxin-absorbing or binding nanoparticles
#37Method of treating amyotrophic lateral sclerosis with pridopidine
#38NON-INFECTIVE NASAL SYMPTOM MANAGEMENT COMPOSITIONS AND METHODS
#39Modulating antibacterial immunity via bacterial membrane-coated nanoparticles
#40DEUTERATED MORPHINAN COMPOUNDS FOR TREATING AGITATION
#41PHARMACEUTICAL COMPOSITIONS COMPRISING DEXTROMETHORPHAN AND QUINIDINE FOR THE TREATMENT OF DEPRESSION, ANXIETY, AND NEURODEGENERATIVE DISORDERS
#42PHARMACEUTICAL COMPOSITIONS COMPRISING DEXTROMETHORPHAN AND QUINIDINE FOR THE TREATMENT OF AGITATION IN DEMENTIA
#43PHARMACEUTICAL COMPOSITIONS COMPRISING DEXTROMETHORPHAN AND QUINIDINE FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
#44Angiopoietin-based interventions for treating cerebral malaria
#45Copolymers including cinchona alkaloid components and one or more acrylamide or acrylate containing components, complexes containing the same, and methods of using the
#46Hydrogel toxin-absorbing or binding nanoparticles
#47Pain Medicine Combination and Uses Thereof
#48PHARMACEUTICAL COMPOSITIONS COMPRISING A DEXTROMETHORPHAN COMPOUND AND QUINIDINE FOR THE TREATMENT OF AGITATION IN DEMENTIA
#49Methods and compounds for treating malaria
#50CNS-accessible pharmacological chaperones for treatment of acid β-glucosidase-related disease states
#51Morphinan Compounds
#52TREATMENT OF NEURODEGENERATIVE DISEASES
#53DEUTERATED MORPHINAN COMPOUNDS FOR TREATING AGITATION
#54MORPHINAN COMPOUNDS FOR TREATING AGITATION
#55DEUTERATED MORPHINAN COMPOUNDS FOR TREATING AGITATION
#56Angiopoietin-based interventions for treating cerebral malaria
#57Use of anti-connexin agents for enhancing the therapeutic effect of acetylcholinesterase inhibitors
#58METHOD FOR ISOLATION OF ALKALOIDS AND AMINO ACIDS, AND COMPOSITIONS CONTAINING ISOLATED ALKALOIDS AND AMINO ACIDS
#59PHARMACEUTICAL COMPOSITIONS COMPRISING DEXTROMETHORPHAN AND QUINIDINE FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
#60Modulating antibacterial immunity via bacterial membrane-coated nanoparticles
#61PHARMACEUTICAL COMPOSITIONS COMPRISING DEXTROMETHORPHAN AND QUINIDINE FOR THE TREATMENT OF DEPRESSION, ANXIETY, AND NEURODEGENERATIVE DISORDERS
#62Injectable anticancer composition for local administration containing suspension of quinine salt
#63PHARMACEUTICAL COMPOSITIONS COMPRISING DEXTROMETHORPHAN AND QUINIDINE FOR THE TREATMENT OF AGITATION IN DEMENTIA
#64Hydrogel toxin-absorbing or binding nanoparticles
#65Morphinan compounds
#66Anti-parasitic methods and compositions utilizing diindolylmethane-related indoles
#67Angiopoietin-based interventions for treating cerebral malaria
#68Pain Medicine Combination and Uses Thereof
#69Application of cinchona alkaloid derivatives as cytotoxic compounds
#70PHARMACEUTICAL COMPOSITIONS COMPRISING DEXTROMETHORPHAN AND QUINIDINE FOR THE TREATMENT OF DEPRESSION, ANXIETY, AND NEURODEGENERATIVE DISORDERS
#71Peyer's patch activator
#72Diagnosis and treatment for respiratory tract diseases
#73FILLER COMPRISING BEADS
#74Morphinan compounds
#75Pain medicine combination and uses thereof
#76SODIUM CHANNEL BLOCKERS REDUCE GLUCAGON SECRETION
#77SNACK SYSTEM, INCLUDING INTERIOR FILING OF INGREDIENT, OUTER COATING OF INGREDIENT, ADDITION OF INGREDIENT, AND FORMATION OF SNACK ROLL
#78Morphinan compounds
#79Method for screening a glutamate release inhibitor in an astrocyte
#80Anti-parasitic methods and compositions utilizing diindolylmethane-related indoles
#81TRPM5 INHIBITORS SUPPORT BODY WEIGHT REDUCTION WITHOUT REDUCING FOOD INTAKE
#82Compositions for transdermal delivery of active agents
#83Treating attention deficit hyperactivity disorder with NHE inhibitors
#84PHARMACEUTICAL COMPOSITIONS COMPRISING DEXTROMETHORPHAN AND QUINIDINE FOR THE TREATMENT OF DEPRESSION, ANXIETY, AND NEURODEGENERATIVE DISORDERS
#85Methods of treating obstructive lung diseases using bitter tastants
#86QUININE DOSAGE FORMS AND METHODS OF USE THEREOF
#87Composition containing cinchonine as an active ingredient for preventing and treating obesity, dyslipidemia, fatty liver, or insulin resistance syndrome
#88Use of inhibitors of scavenger receptor class proteins for the treatment of infectious diseases
#89QUININE FORMULATIONS, METHOD OF MAKING, AND METHOD OF USE THEREOF
#90Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders
#91Methods for treating Kaposi sarcoma
#92Morphinan compounds
#93Morphinan compounds
#94Compounds and compositions useful in the treatment of malaria
#95USE OF ENHANCERS, POSSIBLY ASSOCIATED TO RIBOFLAVIN, AS WELL AS CORRESPONDING OPHTHALMIC COMPOSITIONS FOR CORNEAL CROSS-LINKING IN THE TREATMENT OF THE KERATOCONUS OR OF OTHER CORNEAL ECTASIC DISORDERS
#96Treatment of malaria
#97Pharmaceutical Compositions Comprising Dextromethorphan and Quinidine for the Treatment of Depression, Anxiety, and Neurodegenerative Disorders
#98Fluorine-18 derivatives of dasatinib and uses thereof
#99Nanoparticles for imaging and treating chlamydial infection
#100Encapsulates
#101PHARMACEUTICAL COMPOSITIONS COMPRISING DEXTROMETHORPHAN AND QUINIDINE FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
#102Anti-parasitic methods and compositions utilizing diindolylmethane-related indoles
#103Use of Inhibitors of Scavenger Receptor Class Proteins for the Treatment of Infectious Diseases
#104QUINOLINE COMPOUNDS AS MELANOGENESIS MODIFIERS AND USES THEREOF
#105Therapeutic Use of Methionine to Reduce the Toxicity of Aminoglycoside Antibiotics
#106Delivery of antipsychotics through an inhalation route
#107QUININE DOSAGE FORMS AND METHODS OF USE THEREOF
#108PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF PROTOZOAN PARASITIC DISEASES
#109PHARMACEUTICAL COMPOSITIONS COMPRISING DEXTROMETHORPHAN AND QUINIDINE FOR THE TREATMENT OF DEPRESSION, ANXIETY, AND NEURODEGENERATIVE DISORDERS
#110PHARMACEUTICAL COMPOSITIONS COMPRISING DEXTROMETHORPHAN AND QUINIDINE FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
#111Morphinan compounds
#112Delivery of drug esters through an inhalation route
#113QUININE PRODUCTS, METHOD OF MANUFACTURE, METHOD OF USE
#114Delivery of opioids through an inhalation route
#115QUININE DOSAGE FORMS AND METHODS OF USE THEREOF
#116Film coated tablet for improved upper gastrointestinal tract safety
#117Delivery of muscle relaxants through an inhalation route
#118Compositions and methods for modulating gated ion channels
#119Delivery of antihistamines through an inhalation route
#120Delivery of sedative-hypnotics through an inhalation route
#121Delivery of antipsychotics through an inhalation route
#122Delivery of nonsteroidal antiinflammatory drugs through an inhalation route
#123Quinine dosage forms and methods of use thereof
#124Quinine formulations
#125Delivery of drug esters through an inhalation route
#126Treatment or prevention of pruritus
#127Antagonist and agonist which bind to a strong binding site of chemokine receptor
#128Delivery of erectile dysfunction drugs through an inhalation route
#129Delivery of analgesics through an inhalation route
#130Delivery of physiologically active compounds through an inhalation route
#131Delivery of diphenhydramine through an inhalation route
#132Delivery of anti-migraine compounds through an inhalation route
#133Delivery of antidepressants through an inhalation route
#134Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route
#135Treatment of eczemas
#136Dermatological compositions and salts for the treatment of dermatological diseases
#137Delivery of compounds for the treatment of Parkinson's through an inhalation route
#138Delivery of beta-blockers through an inhalation route
#139Delivery of antiemetics through an inhalation route
#140Therapeutic use of methionine-derivitives to reduce the toxicity of noise
#141Delivery of stimulants through an inhalation route
#142Treatment of inflammatory disorders
#143Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders
#144Pharmaceutical combination of artesunate and mefloquine for therapy of malaria
#145Delivery of sedative-hypnotics through an inhalation route
#146Delivery of opioids through an inhalation route